基于特定SNP的多重PCR同时鉴定当归补血丸两种生物成分
该研究针对中成药当归补血丸,基于nrITS高变区设计物种特异性引物,建立多重PCR法同时鉴定当归和黄芪。
要点
- 多重PCR可同时鉴定当归补血丸中当归与黄芪两种成分。
- 方法灵敏度最低检测浓度4.0×10-3 ng/μL,最优退火温度65°C。
- 可替代耗时耗力的常规PCR用于中成药生物成分质控。
核心结论
- 基于SNP的多重PCR可简单、省时省力地同时鉴定当归补血丸中当归和黄芪两种生物成分。
主要发现
- 筛出两对高物种特异性引物,分别扩增当归和黄芪。
- 建立的多重PCR在65°C退火温度下特异性高,最低检测浓度为4.0×10-3 ng/μL。
- 该方法可同时鉴定当归补血丸中两种生物成分。
关键数值与推荐
- 最优退火温度为65°C。
- 最低检测浓度为4.0×10-3 ng/μL。
临床怎么用
- 可用于当归补血丸中当归和黄芪成分的同时定性鉴定。
- 为中成药生物成分真实性监督提供省时省力的分子检测策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: An increasing number of Chinese patent medicines (CPM) have been widely used in East Asian and North American countries, and the safety and efficacy of CPM have highly attracted public attention. However, it is difficult to supervise the authenticity of multiple biological ingredients within CPM based on microscopic inspection and physical and chemical detection. The raw materials may have similar characteristics of tissue structures and ergastic substances or similar chemical composition and contents when substitutes and/or adulterants are added. DNA molecular markers have been used to distinguish the biological ingredients within CPM based on conventional PCR assay. However, it was proved to be time- and labor-consuming and reagent-wasting, as multiple PCR amplification strategies were required for identifying the complex species composition within CPM. Here, we took the CPM (Danggui Buxue pill) as an example and aimed to establish a specific SNP-based multiplex PCR assay and simultaneously determine the authenticity of the two biological ingredients (Angelicae Sinensis Radix and Astragali Radix) within this CPM. Methods: We, respectively, designed the species-specific primers based on highly variable nrITS for discriminating Angelicae Sinensis Radix and Astragali Radix from their common substitutes and adulterants. The specificity of the primers was checked through conventional PCR assay and multiplex PCR assay. Furthermore, we used a handcrafted Danggui Buxue pill sample (DGBXP) to optimize annealing temperatures for the primers with multiplex PCR, and the sensitivity was also assessed. Finally, fourteen batches of commercial Danggui Buxue pills were used to verify the stability and practicability of the established multiplex PCR assay. Results: Two pairs of highly species-specific primers for amplifying Angelicae Sinensis Radix and Astragali Radix were screened, and our established multiplex PCR assay showed high specificity and sensitivity (lowest detection concentration: 4.0 × 10-3 ng/μL) at an optimal annealing temperature of 65°C. The method could simultaneously identify both biological ingredients within the Danggui Buxue pill. Conclusion: The specific SNP-based multiplex PCR provided a simple, time-, and labor-saving method for the simultaneous identification of the two biological ingredients within Danggui Buxue pills. This study was expected to provide a novel qualitative quality control strategy for CPM.
引用
- Liu Y, Yang Y, Zhou Z, et al. A specific SNP-based multiplex PCR assay for the simultaneous identification of two biological ingredients for the Chinese patent medicine, Danggui Buxue pill. Front Pharmacol. 2023. PMID: 37251312. doi:10.3389/fphar.2023.1098598
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。